CTA1-DD/M2e vaccine (Goteborg University)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCTA1-DD/M2e vaccine (Goteborg University)
Drug Alias NameCTA1-M2e-DDprotein fusion vaccine (Goteborg University)CTA1-3M2e-DD
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Gothenburg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Gothenburg
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A